NCT02304900

Brief Summary

The cataract surgery (550 000 operations per year in France) is to replace the cloudy lens with a refractive implant. Two colors of implants are available: white implants, filtering out ultraviolet and yellow implants, filtering and more blue light. No clinical data are available to assert the superiority of an implant according to its color and the choice is made according to the preference of the surgeon and / or "markets". It is established in humans that blue light has an important role on the secretion of melanopsin, a key mediator of the circadian cycle. This "clock" regulates most neuroendocrine functions in the nycthémère (sleep, mood, temperature, cortisol, ..). The question of the impact of these neuro endocrine functions of the installation of a blue light filter into the eyes of patients operated thus arises.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2009

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2009

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

November 27, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 2, 2014

Completed
Last Updated

December 22, 2025

Status Verified

February 1, 2017

Enrollment Period

2 years

First QC Date

November 27, 2014

Last Update Submit

December 15, 2025

Conditions

Keywords

cataract

Outcome Measures

Primary Outcomes (1)

  • Variation between before and 2 months after surgery sleep time

    2 months

Secondary Outcomes (3)

  • Variation between before and 2 months after surgery the number of hours of sleep

    2 months

  • Variation between before and 2 months after surgery of the quality of sleep

    2 months

  • Variation between before and 2 months after surgery the mood evaluation score

    2 months

Study Arms (2)

Group 1 : white implant

EXPERIMENTAL

Randomization will determine the color of the implant to be used for each patient for interventions in both eyes, white or yellow to know.

Other: white implant

Group 2 : yellow implant

EXPERIMENTAL

Randomization will determine the color of the implant to be used for each patient for interventions in both eyes, white or yellow to know.

Other: yellow implant

Interventions

1. st intervention (in the month following the inclusion): Randomization of the color of the implant 2. nd operation (1 to 3 months after the first surgery): Installation of a same color as the first implant operated eye

Group 2 : yellow implant

1. st intervention (in the month following the inclusion): Randomization of the color of the implant 2. nd operation (1 to 3 months after the first surgery): Installation of a same color as the first implant operated eye

Group 1 : white implant

Eligibility Criteria

Age60 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • female or male subject
  • subject between 60 and 90 years old
  • Visual acuteness \< or = with 2 eyes
  • Indication operating of the cataract

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Service d'Ophtalmologie

Brest, France

Location

Service d'Ophtalmologie, Centre Hospitalier Paul Martinais

Loches, 37600, France

Location

Service d'Ophtalmologie

Tours, 37, France

Location

Related Publications (1)

  • Zambrowski O, Tavernier E, Souied EH, Desmidt T, Le Gouge A, Bellicaud D, Cochener B, Limousin N, Hommet C, Autret-Leca E, Pisella PJ, Camus V. Sleep and mood changes in advanced age after blue-blocking (yellow) intra ocular lens (IOLs) implantation during cataract surgical treatment: a randomized controlled trial. Aging Ment Health. 2018 Oct;22(10):1351-1356. doi: 10.1080/13607863.2017.1348482. Epub 2017 Jul 10.

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 27, 2014

First Posted

December 2, 2014

Study Start

December 1, 2009

Primary Completion

December 1, 2011

Study Completion

December 1, 2012

Last Updated

December 22, 2025

Record last verified: 2017-02

Locations